WallStreetZenWallStreetZen

NASDAQ: SLGC
Somalogic Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SLGC

Based on 3 analysts offering 12 month price targets for Somalogic Inc.
Min Forecast
$5.00+57.23%
Avg Forecast
$6.33+99.15%
Max Forecast
$7.00+120.13%

Should I buy or sell SLGC stock?

Based on 3 analysts offering ratings for Somalogic Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SLGC stock forecasts and price targets.

SLGC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
TD Cowen
Top 15%
86
BuyMaintains$7.00+120.13%2023-03-29
Stifel Nicolaus
Top 9%
92
Strong BuyMaintains$7.00+120.13%2023-03-29
Canaccord Genuity
Bottom 5%
5
Strong BuyMaintains$5.00+57.23%2023-03-29

1 of 1

Forecast return on equity

Is SLGC forecast to generate an efficient return?
Company
-10.53%
Industry
6.99%
Market
89.46%
SLGC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SLGC forecast to generate an efficient return on assets?
Company
-9.18%
Industry
9.89%
SLGC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SLGC revenue growth forecast

How is SLGC forecast to perform vs Health Information Services companies and vs the US market?
Company
27.78%
Industry
19.57%
Market
8.91%
SLGC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SLGC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SLGC vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
SLGC$3.18$6.33+99.15%Strong Buy
SHCR$1.59$2.00+25.79%Hold
HCAT$11.27$15.00+33.10%Strong Buy
AMWL$2.29$4.24+85.28%Buy
HSTM$23.18$26.00+12.17%Hold
View Top Health Information Service Stocks

Somalogic Stock Forecast FAQ

Is Somalogic Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SLGC) stock is to Strong Buy SLGC stock.

Out of 3 analysts, 2 (66.67%) are recommending SLGC as a Strong Buy, 1 (33.33%) are recommending SLGC as a Buy, 0 (0%) are recommending SLGC as a Hold, 0 (0%) are recommending SLGC as a Sell, and 0 (0%) are recommending SLGC as a Strong Sell.

If you're new to stock investing, here's how to buy Somalogic stock.

What is SLGC's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: SLGC) forecast ROE is -10.53%, which is considered weak.

What is SLGC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SLGC price target, the average SLGC price target is $6.33, with the highest SLGC stock price forecast at $7.00 and the lowest SLGC stock price forecast at $5.00.

On average, Wall Street analysts predict that Somalogic's share price could reach $6.33 by Mar 29, 2024. The average Somalogic stock price prediction forecasts a potential upside of 99.15% from the current SLGC share price of $3.18.

What is SLGC's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: SLGC) forecast ROA is -9.18%, which is lower than the forecast US Health Information Services industry average of 9.89%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.